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that interesting work secures repetition of movements without undue 
fatigue. Not only must the physician take into consideration, 
therefore, the type of movements produced by the work which he 
is about to prescribe, but also the desires and interests of the patient. 
We found that the soldiers in the hospital took kindly to occupa¬ 
tional therapy, and often in spite of their disabilities produced 
work which from an artistic and technical point of view was of a 
high order. From a study of these cases over a period of more 
than a year it became evident that the results of this form of treat¬ 
ment entitle it to an important place among the therapeutic agents 
at our disposal in the treatment of injuries presenting paralysis, 
contracture, fibrosis or lack of coordination. In view of the fact 
that occupational therapy has been proved to be of definite value 
in the treatment of various other conditions, possibly the day is 
not far distant when an occupational therapy department, under a 
trained supervisor, will be recognized ns a necessary part of the 
equipment of every up-to-date hospital. 
SOME OBSERVATIONS ON THE USE OF ARSPHENAMIN: ITS 
EFFECT ON THE KIDNEVS AND ITS THERAPEUTIC 
RESULTS. 
By Horace B. Anderson, M.D., 
PENNSYLVANIA HOSPITAL, PHILADELPHIA. 
Recent medical literature is pregnant with articles either extolling 
the virtues of salvarsan and arsphenamin by reporting series of 
cases in which observations on the clinical manifestations and 
serologic reactions have indicated the therapeutic value of the drug 
or abusing and condemning the use of it by reporting all manner of 
reactions varying from the mild vasomotor disturbances to fatali¬ 
ties. It is the purpose of this paper to do neither the one thing nor 
the other, but rather to take the opposite ground; to submit some 
evidence, after studying 39 cases which have had twenty or. more 
doses of arsphenamin, to show the non-toxic effect of the drug on 
the kidneys when administered in therapeutic doses over a compara¬ 
tively long period of time and at the same time to give some data 
concerning its value as a therapeutic agent. 
Concerning the gross and histopathologic changcsof acute arsphen¬ 
amin poisoning we have already acquired considerable information 
from the studies and reports of Kolmer1 and others, but concerning 
the chronic poisoning we have less information largely because of 
the comparatively recent use of the drug. In the future, no doubt, 
1 Am. Jour. Med. Sc.. 1920, clx. 188. 
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we will have a more accurate knowledge of the pathologic effects 
of its prolonged use and can come more nearly answering the 
important question, “What changes are produced in the kidneys 
by the prolonged use of arsphenamin?” One only appreciates the 
importance of such a question when he reflects on the fact that 
thousands of doses of arsphenamin are being administered every 
day ter patients throughout the country and by the energetic 
application of their plans to eradicate syphilis the U. S. P. II. 
Service and the State boards of health are increasing daily the 
number of patients treated. 
In this clinic prior to 1918 it was the policy to give weekly injec¬ 
tions continuously as long as the patients would submit to it and the 
Wassermann reaction was positive. Since that date the policy has 
been to administer a course of arsphenamin consisting of six weekly 
injections, the dose being, unless contra-indicated, 1 decigram per 
thirty pounds body weight followed by a ten weeks’ course of 
mercury in the form of the inunctions, the protoiodides or injections 
of the salicylate of mercury and after this a rest of one month with¬ 
out treatment. During the second and third year the same plan of 
treatment is used, but the duration of the course is modified some¬ 
what to meet the clinical aspect of the case, the serologic findings 
and the mental attitude of the patient. 
Wassennann tests are taken every second week while arsphenamin 
is being given and at the end of each course of mercury. Acetone 
insoluble and alcoholic extract reinforced by cholesterin antigens 
are used in all tests. 
It was possible to study the kidney function of 39 patients who 
had had over twenty doses of arsphenamin. The phenolsulphone- 
phthalein tests were performed after the method of Rowntree and 
Geraghty,2 the urea nitrogen, non-protein nitrogen and creatinin 
after the method of Folin and Wu3 and those cases that showed 
albumin in the urine by the heat and nitric acid tests were further 
tested for globulin by the use of ammonium sulphate, etc., as 
described by Hawk.4 The data of kidney function tests is given in 
Table I. 
The average number of treatments for these 39 cases is approxi¬ 
mately 30 doses, consisting of 4.6 decigrams each distributed over a 
period of a littic over two years. To state it another way these 
patients have had an average of 14 treatments of arsphenamin per 
year for about twenty-six months. The preparations used have 
varied but in the main consisted of arsenobenzol, "Billion” arsphe¬ 
namin, Metz and all later treatments have been of arsphenamin 
made by the Dermatological Research Laboratory of Philadelphia. 
1 Jour. Pharm. and Exper. Therap., 1910, i, 579. 
1 Jour. Biol. Chem., 1916, xxxviii, 81. 
* Praot. Phys. Chem., 1918, 0 ed., p. 454. 
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0 2M 24 17.5 l 4 00 13 1020 0 0 0 32 15 1.8 
3 281 50 20.8 4 0 55 18 1018 0 0 0 27 17 2.2 
4 fillfi 27 130 0 2 00 23 10211 0 0 0 33 12 1.7 
000 52 20.0 1 7 55 IN 1024) 0 0 0 30 13 2.2 
0 034 42 15.4 3 2 55 18 1012 Fuint tr. 0 0 28 13 1.0 
7 047 29 13.8 4 30 15 1013 0 0 0 40 14 2.0 
8 432 20 12.9 1> 70 15 1025 0 0 0 34 17.5 2.4 
9 410 28 14 2 1 0 I.OSt 1020 0 0 0 33 10 2.0 
1(1 37(1 38 15.0 2 11 05 13 1023 0 0 0 25 10 1.5 
11 11(17 35 11.7 1 8 25 20 1025 0 0 0 31 17 1.8 
12 810 44 20.0 3 0 50 20 1023 0 0 0 34 15 1.5 
13 08 38 13.0 6 3 05 12 1010 0 u 0. 28 12 2.3 
11 •Ol 30 15.0 3 0 (HI 13 1021 O 0 0 37 17 2.0 
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20 04 32 13.4 4 9 All 10 mm 0 0 0 28 12 2.3 
21 109 25 10.0 1 11 00 15 lUlo Tr., nono 
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0 0 31 20 2.0 
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24 220 22 9.35 11 55 20 1025 Very fuint 
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0 0 37 20 1.3 
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0 37 17 1.0 
211 758 34 15.0 2 00 15 1024 0 0 0 33 12 1.0 
27 582 31 12.8 l 8 III) 10 1021 0 0 0 35 17 1.5 
28 205 21 11.5 1 15 1020 _ o 0 35 
20 505 22 11.0 2 4 30 15 1012 Cloudy, 
alb. aud 
glob. 
0 0 29 14 1.0 
30 585 32 15.1 1 0 30 15 1015 0 0 0 29 14 
31 240 34 15.5 1 11 (HI 15 1025 0 0 0 31 13 1.7 
32 275 20 7.0 2 1 00 11) 1015 0 0 0 42 15 1.0 
33 232 20 0.0 1 4 00 15 1020 0 0 0 40 20 1.0 
34 100 28 138 1 11 55 20 1024 0 0 0 40 18 1.7 
35 18 23 ll.fi 1 55 10 1024 0 0 0 34 17 1.7 
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30 268 20 13.4 1 a U5 10 1020 0 0 0 33 13 1.8 
A table giving the anphcnamin received, tho duration of treatment, the ohenolaulphonephtka- 
Icin output of two kidneys and the urine nnd blood examination of patients having had twenty or 
more doses of arsphenamin. 
With the exception of patient No. 25, who was transferred from 
the medical clinic, where lie was first seen and diagnosticated tabes 
and nephritis, there is no conclusive p oof of an existing nephritis 
in any of these cases. At that time and at all subsequent examina¬ 
tions the urine of patient No. 25 showed some casts and albumin. 
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Ilis condition apparently is no worse now than when treatment was 
first instituted. Judging from the phenolsulphonephthalein output 
and he albumin and casts in the urine this patient has some nephro¬ 
pathy, but the evidence is in favor of its having been acquired prior 
to treatment. Patients Nos. 6, 21, 24 respectively show a trace of 
albumin at one examination, but there is no other evidence of a 
nephritis. Patient No. 29 shows a cloud of albumin, hut when 
appropriate tests were used it was discerned that more than 50 
pet cent, of the protein precipitate was globulin. This case is well 
clinically, shows no other evidence of nephritis in the other examina- 
tiojns and therefore might be a ease of non-nephritic proteinuria. 
jThe data of table No. 1 lead in general to the conclusion that no 
demonstrable kidney damage has been done. There is, of course, 
nothing to show whether or not there has been any limitation of 
the wide factor of safety which the kidney naturally possesses. 
Several of the patients show a decreased phthalein output which 
one may interpret as one will. 
The efficiency of any new system of treatment must be determined 
ultimately by the Wassennann reaction, for it has long been known 
that negative clinical manifestations arc no guide to the patient’s 
potential syphilitic state. 
The technic employed in our laboratory for doing Wnssermann 
tests has been modeled after that described by II. K. Dctweilcr.6 
We use, however, only 0.1 c.c. of patient’s serum and use the water- 
bath instead of dry heat for incubation. Detwciler’s method of 
daily titrations of the complement as well as the amboceptor has 
proved very satisfactory. The antisheep hemolytic system is 
employed. 
Two antigens arc used, the acetone insoluble and the cholesterin 
reinforced alcoholic extract, made after the method described by 
Kolmer.6 These antigens are titrated every six weeks for their 
antigenetic and anticomplementary values. The former is tested 
on the pooled sera of patients who both clinically and serologically 
are luetic. 
In our experience with cliolesterized antigen it is the more sensitive 
and the last to become negative. The acetone insoluble is far more 
liable to be a correct index to the true condition when positive, 
but often fails to give a positive reaction in the early and late stages 
and also after a limited amount of treatment. This fact is demon¬ 
strated in Tables III, IV and V. Although it is true that a choles- 
terinized antigen will not infrequently give a false positive reaction, 
we believe it is the most valuable antigen that can be employed as a 
guide to treatment. 
* Am. Jour. Syph., 1918, il. 120-137. 
* Inf. Immunity and Spec. Ther., 1917, 2d cd., p. 446. 
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TABLE III.—IN THESE TEN CASES TIIE CHOLESTERINIZED ANTIGEN IS 
APPARENTLY MORE SENSITIVE THAN THE ACETONE 
INSOLUBLE ANTIGEN. 
lory | 809 P.P. OOO 1059 ; 1003 1 1080 j 1043 i 980 1007 ! 1049 
No*! ! ! I ! I i I I | 
Lsioni Chancre' Cliancrc., Chancre.! second- j Chancre.' Chancre.! second- j Chancre.! Chancre.! nJocular 
<1.5 1 V g IVosb. | Woos. . Woss. 
c i : 
Woos. Woss. I Woss. I Woss. Wass. Wa 
C. A. j C. A 
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TABLE V.—UNDER TREATMENT THE CHOLESTERINIZED ANTIGEN OFTEN 
REMAINS POSITIVE AFTER THE ACETONE INSOLUBLE ANTIGEN 
HAS BECOME NEGATIVE. 
alcoholic n'.fe T'lTf ."‘‘I1 *ce,°"? i"0'"1* (A) and clioloalcrini.cd 
?VnMPrm»Cnnra ThS* Scn- Tu? fi5°re8 1*°,4 mcnn, " Mscrmnnn 1 lo 4 plus, - implies n negative 
” a«sermani>- The specimens of blood were taken at the time of the weekly injection of arsphenainin. 
When we make a study of Table II wc find 17 of the 39 cases have 
now had a negative Wasserinann reaction for a year or more. Nine 
of the group have had a negative reaction for less than one year and 
13 of the 39 cases continue to have weakly positive and strongly 
positive reactions. Of those with persistently negative reactions 
for a year or more 2 were in the primary stage, 4 were in the second¬ 
ary and 11 in the tertiary and latent stages. The average number 
of doses to produce persistently negative Wasserinann reactions in 
this group was 1S.7, for those ill the primary stage 12, for those in 
the secondary stage 12.( and in the tertiary and latent stages 21.3 
doses. 
For the 39 patients the average salvarsan per patient has been 130 
decigrams and the average time of treatment one hundred and 
seventeen weeks. This treatment has resulted in making 17 out 
of the 39, or 43 per cent, of the patients clinically and serologically 
negative for a year or more. Seven more patients, IS per cent!, 
have had more than two persistently negative Wassermanns, so 
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that, on the whole, more than half of these 39 patients already have 
a very favorable outlook as far as the ultimate outcome of their 
treatment is concerned. This 61 per cent, of the patients has had 
an average of 4.9 courses of six weeks of mercury in some form or 
TABLE VI.—SECONDARY STAGE. ■ 
10 
11 
12 
13 
14 
15 
in 
17 
172 
315 
247 
257 
324 
020 
390 
014 
412 
507 
843 
035 
855 
085 
738 
870 
Number of 
positive 
iWasscrraanns 
Decigrams 
araphenamin 
to first 
persistent 
negative 
Wa&sermann, 
Weeks to 
first persist- [ Tolnl Total 
weeks. 
53 
38 
30 
51 
20 
07 
55 
47 
142 
05 
30 
5 
32 
30 
52 
44 
48 
70 
78 
(>0 
05 
47 
112 
85 
Number of 
persistent 
negative 
Wasscrmnnns 
TABLE VII.—TERTIARY STAGE. 
i | Decigrams J . 
Case | Number ol «'»cks to j Number of 
No. positive ."J81. | Persist- f Total i Tolnl persistent 
]Wassernmnns persistent lent negative 'nrsplionninin/ weeks. negative 
: negative , Wosscrmann. 
*» assernmnn. 
. IIVK'IUVC 
Wasscrmnnns 
237 
102 
05 
57 
34 
72 
77 
in fables 0 and 7, which are composed of cases now negative 
mt presented secondary and tertiary lesions on admission, and in 
the majority of eases more than one positive Wassennann reaction, 
1 believe we get a fair index as to the efficiency or inefficiency, as 
you may choose to call it, of our present method of treatment, 
t lie average amount of treatment necessary to produce the first 
persisting negative Wnssermann reaction in the group of secondary 
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cases was 52 decigrams and the average time twenty-eight weeks, 
lhat is to say, they received 10.2 doses of arsphenamin consisting 
of 5 decigrams each. The average case, therefore, in this group did 
not give a persisting negative reaction until near the end of the 
second course of treatment. 
It took an average of 62 decigrams to produce a persisting nega¬ 
tive W assermann reaction in the tertiary group. The time averaged 
seventy-two weeks. This means that it was during the third course 
of arsphenamin that they began to show a negative reaction. This 
at first seems better than the situation with the patients of Table 
II, but it is to be understood that for the patients of these latter 
tables more relapses may be expected. We frequently see patients 
who having received six to twelve doses of arsphenamin have been 
discharged with a negative Wassermann only to return within about 
a year both clinically and serologically positive. 
Summary. 1. Because of its extensive use at present it is highly 
important that we know more perfectly the effects of the prolonged 
use of arsphenamin on the kidneys. 
2. Kidney functional tests on 39 cases after they have received 
thirty do es of arsphenamin, each dose consisting of 4.6 decigrams, 
and distributed over a two-year period, fail to give any conclusive 
evidence of injury to the kidneys. 
3. *lhe efficiency of any method of treatment must ultimately 
be determined by the Wassermann reaction. It is more trust¬ 
worthy to use at least two antigens; the acetone insoluble antigen 
is a safe guide to diagnosis and the alcoholic extract reinforced by 
cholestcrin is an excellent guide to treatment. 
4. It is impossible to say how much arsphenamin and how' many 
courses of mercury may be necessary to produce a negative Wasser¬ 
mann reaction in any given case. 
5. Six injections of arsphenamin and one course of mercury, the 
amount too often prescribed by certain groups of physicians, may 
produce one negative Wassermann reaction, but the average case 
of secondary or tertiary syphilis will require twelve or more doses 
of arsphenamin and a corresponding amount of treatment with 
mercury to produce a negative Wassermann reaction, and one which 
only with further treatment may reasonably be expected to persist. 
